Rethinking Antimicrobial Prophylaxis in the Transplant Patient in the World of Emerging Resistant Organisms-Where Are We Today?

导出 OA

翻译打印收藏纠错

作者： Lucy E,Horton ^[1] ; Nina M,Haste ^[2] ; Randy A,Taplitz ^[3]

作者单位： Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, 9500 Gilman Drive, Mail Code 0960, La Jolla, CA, 92093-0711, USA. ^[1] Department of Pharmacy, University of California San Diego, 9500 Gilman Drive, La Jolla, CA, 92093-0711, USA. ^[2] Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, 9500 Gilman Drive, Mail Code 0960, La Jolla, CA, 92093-0711, USA. rtaplitz@ucsd.edu. ^[3]

关键词 Antibiotic prophylaxis Bone marrow transplant (BMT)Graft-versus-host-disease (GVHD), microbiome Hematopoietic stem cell transplant (HSCT)Neutropenia

主题词抗菌药(Anti-Bacterial Agents);梭菌感染(Clostridium Infections);抗药性, 细菌(Drug Resistance, Bacterial);移植物抗宿主病(Graft vs Host Disease);造血干细胞移植(Hematopoietic Stem Cell Transplantation);人类(Humans);中性粒细胞减少(Neutropenia)

DOI 10.1007/s11899-018-0435-0

PMID 29374371

发布时间 2020-12-09

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交